Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urologic applications of botox.

Courtenay Moore1, Raymond Rackley, Howard Goldman

  • 1Cleveland Clinic Foundation, Glickman Urological Institute, A-100, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Current Urology Reports
|October 22, 2005
PubMed
Summary

Botulinum toxin (BTX), a neurotoxin from Clostridium botulinum, temporarily blocks acetylcholine release, causing flaccid paralysis. This effect is utilized in medicine to treat various neuromuscular disorders and has shown promise in urology for conditions like detrusor overactivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of behavioral health service use among dually eligible, Medicaid-only, and Medicare-only beneficiaries.

BMC health services research·2026
Same author

Examining Employment Trajectories of Individuals With Mental Disorders.

Psychiatric services (Washington, D.C.)·2026
Same author

Functional improvement is a better predictor of steady work than medical improvement for individuals with mental health conditions.

PLOS mental health·2026
Same author

Functional improvement is a better predictor of steady work than medical improvement for individuals with mental health conditions.

medRxiv : the preprint server for health sciences·2025
Same author

Increasing the Value of Health Intervention Trials: Qualitative Research in the Early Psychosis Intervention Network (EPINET).

Community mental health journal·2025
Same author

Youth Inpatient and Residential Treatment Psychiatric Beds: National Trends and Potential Causal Factors, 2010-2022.

Psychiatric services (Washington, D.C.)·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Bacteriology

Background:

  • Botulinum toxin (BTX) is a neurotoxin produced by Clostridium botulinum.
  • It functions by inhibiting acetylcholine release at the neuromuscular junction, inducing temporary flaccid paralysis.
  • This mechanism has been leveraged to treat conditions involving muscular hypercontraction.

Purpose of the Study:

  • To review the medical applications of Botulinum toxin.
  • To highlight its established uses and emerging applications in various medical disciplines.
  • To summarize its efficacy in treating neuromuscular disorders and urological conditions.

Main Methods:

  • Literature review of Botulinum toxin's mechanism of action and clinical applications.
  • Analysis of FDA-approved uses and off-label therapeutic uses.

Related Experiment Videos

  • Examination of its role in treating strabismus, blepharospasm, and various neuromuscular and urological disorders.

    • Main Results:

    • Botulinum toxin (BTX) was first FDA-approved in 1989 for strabismus and blepharospasm.
    • It is widely used for diverse neuromuscular disorders due to its muscle-relaxing properties.
    • BTX demonstrates successful off-label use in urology for conditions such as detrusor overactivity and chronic pain.

    Conclusions:

    • Botulinum toxin (BTX) is a valuable therapeutic agent for managing neuromuscular hypercontraction.
    • Its established efficacy in ophthalmology and neurology is complemented by promising applications in urology.
    • Further research may support broader clinical adoption of BTX for a wider range of conditions.